OpenAlex
PricingAboutJobs
Log inGet started
Work

Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects

HTML

Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: American Journal of Nephrology
DOI: 10.1159/000454818
Authors: Tadao Akizawa, Yoshiharu Tsubakihara, Masaomi Nangaku, Yukihiro Endo, Hiromu Nakajima, Tomoko Kohno, Yukiko Imai, Natsumi Kawase, Katsutoshi Hara, John Lepore, Alexander Cobitz
Institutions: SHOWA Medical University, Graduate School of Health Care Sciences, Jikei Institute, The University of Tokyo, GlaxoSmithKline (Japan), GlaxoSmithKline (United States)
Language: English

Topic: Erythropoietin and Anemia Treatment
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: daprodustat, hypoxia-inducible factor prolyl hydroxylase inhibitor, anemia of chronic kidney disease, hemodialysis, hemoglobin response, erythropoietin, vascular endothelial growth factor, dose-dependent effects, Japanese patients
SDG: Good health and well-being

Open Access status: closed

Funders: GlaxoSmithKline, Japan Society for the Promotion of Science
Award: G4018883650
OpenAlex ID: W2562262017
FWCI: 5.933
Cites: 24
Cited by: 108
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security